R, Z., W, Y., Y, W., L, X., F, S., D, L., . . . H, L. (2022). Dnah9 mutant mice and organoid models recapitulate the clinical features of patients with PCD and provide an excellent platform for drug screening. Cell death & disease, 13(6), 559. https://doi.org/10.1038/s41419-022-05010-5
Chicago Style (17th ed.) CitationR, Zheng, et al. "Dnah9 Mutant Mice and Organoid Models Recapitulate the Clinical Features of Patients with PCD and Provide an Excellent Platform for Drug Screening." Cell Death & Disease 13, no. 6 (2022): 559. https://doi.org/10.1038/s41419-022-05010-5.
MLA (9th ed.) CitationR, Zheng, et al. "Dnah9 Mutant Mice and Organoid Models Recapitulate the Clinical Features of Patients with PCD and Provide an Excellent Platform for Drug Screening." Cell Death & Disease, vol. 13, no. 6, 2022, p. 559, https://doi.org/10.1038/s41419-022-05010-5.